Aruna D. Pradhan

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Aruna D. Pradhan · JAMA · 2001 · 4.4K citations

Veterinary Medicine, Immunology, Disease Prevention +12

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Paul M. Ridker, Aruna D. Pradhan, Jean MacFadyen et al. · The Lancet · 2012 · 810 citations

Medicine, Cardiology, Preventive Medicine +15

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart et al. · New England Journal of Medicine · 2022 · 711 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16